Topics Related to Pharmacy Providers

Magellan Medicaid Administration, LLC has been awarded a contract to implement the solution, scheduled to launch in 2025.

This bulletin is replaced by Additional NC Medicaid Respiratory Syncytial Virus (RSV) Guidelines for 2023-2024 published on Jan. 24, 2024.

Effective Nov. 1, 2023, NC Medicaid will remove all copay requirements for antiretroviral medications which decrease viral load in patients with HIV.

This bulletin is replaced by NC Medicaid Respiratory Syncytial Virus (RSV) Guidelines for 2023-2024 - Revised

Includes information on vaccine reimbursement, billing, counseling coverage and Immunization Program/Vaccines for Children

Effective Oct. 1, 2023, copays will no longer be required for adult vaccines and vaccine administration.

Vaccine strains for the 2023–24 influenza vaccines were selected by the Food and Drug Administration’s Vaccines and Related Biologic Products Advisory Committee based on WHO’s recommended Northern Hemisphere 2023–24 influenza vaccine composition.

This bulletin replaces NC Medicaid Temporary Flexibilities Due to Hurricane Idalia published on Aug. 30, 2023, to correct the end date.

Provider guidance for reimbursement, enrollment and providing care for Medicaid beneficiaries

Clinical Coverage Pharmacy Policy 9 will allow for donation of abandoned Long-Acting Injectable Antipsychotics to a registered Drug Repository Program